Prevention of hepatitis B virus reactivation under rituximab therapy. - Wikidata - awgldk - TriplyDB

Prevention of hepatitis B virus reactivation under rituximab therapy.

Prevention of hepatitis B virus reactivation under rituximab therapy.

http://www.wikidata.org/entity/Q33390799

about

Hepatitis B virus reactivation with a rituximab-containing regimen Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)Hepatitis B virus management to prevent reactivation after chemotherapy: a review.Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center.HCV virus and lymphoid neoplasms Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.Screening for hepatitis B in patients with lymphoma.The impact of biologic response modifiers on hepatitis B virus infection.Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis.Rituximab administration and reactivation of HBV.Impact of Immunochemotherapy-Related Hepatic Toxicity on the Outcome of HCV-Positive Diffuse Large B-Cell Lymphoma Patients

P2860

Q26785963-A6CEEA93-EB54-44D7-963D-E65B9B395551 Q26801716-68D99964-B76F-4B94-A9C6-5A10A62E355A Q34397738-77FED3FA-D493-417D-825A-0123BB539FE0 Q35037621-3D795957-0B5B-44B0-BD7B-8EC75742504B Q35089842-8F470495-4F83-4236-B87E-40D674D3F4EA Q36001152-429600C3-64BD-4949-A924-EF50A1E9EA7B Q36058282-55FC8229-C415-4548-94BE-714EB1A16CEC Q37832503-80001B58-A814-4920-8A73-1546600DD11C Q40285910-1AD7DEC3-99B7-4A3F-BC9B-66C7D8461DA2 Q41215683-C33DE89F-7150-42BA-B96E-CAA6D71A4D60 Q59052762-D17AE145-E1C8-48CF-997D-3CD7F4AD3819

P2860

Prevention of hepatitis B virus reactivation under rituximab therapy.

http://www.wikidata.org/entity/Q33390799

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Prevention of hepatitis B virus reactivation under rituximab therapy.

@ast

Prevention of hepatitis B virus reactivation under rituximab therapy.

@en

type

label

Prevention of hepatitis B virus reactivation under rituximab therapy.

@ast

Prevention of hepatitis B virus reactivation under rituximab therapy.

@en

prefLabel

Prevention of hepatitis B virus reactivation under rituximab therapy.

@ast

Prevention of hepatitis B virus reactivation under rituximab therapy.

@en

P1433

Q33390799-1DA7AFFE-D693-4AA0-9436-B9EA04D333F1

P1476

Q33390799-05F85905-522A-46F4-8CFC-E83FB463462F

P2093

Q33390799-02575651-8D2B-4D63-93CE-50D21B7E22D9

Q33390799-1C67045B-A183-4224-96D4-5EEFB23E4EF0

Q33390799-30898A65-5C13-4C9B-B6AD-C4C087E17742

Q33390799-4832D5CC-F888-45B1-A5F0-A85C384B15F1

Q33390799-A45D92B3-D972-47CC-A601-747CC7F891D1

P2860

Q33390799-00C07AA2-E8B2-4F11-ACB4-3326BBA940E4

Q33390799-051435F2-48EB-492E-9652-4C7877F403DF

Q33390799-06228BBF-4917-49E1-9094-05B794CED0FB

Q33390799-07D04D80-34D0-4F82-8F05-5B655AD683A5

Q33390799-100D05E3-1D63-4221-8832-A7846AFC2631

Q33390799-1342C099-46BB-475A-9557-F25FA08D0C15

Q33390799-13E4535C-8EDD-46FB-8FBB-652C1489316F

Q33390799-19EF60D3-431F-4A9A-A80A-1AC534B549BD

Q33390799-1C34A438-FBE5-4168-90BF-CD36077E78D8

Q33390799-20F09A3D-B83F-4A4A-A01A-5B8B7C57B588

P304

Q33390799-067AD761-FB29-4CC9-8887-9CD9AB27C764

P31

Q33390799-E0191090-3599-4824-90BB-56B675386F5B

P356

Q33390799-B390DFFD-369F-407C-B352-671CA5DC1AF4

P433

Q33390799-814F21AA-2C2E-49ED-B06D-B6D6A66D8D1D

P478

Q33390799-5B3F69EA-0A06-462C-A6D3-713A81A7F6CB

P50

Q33390799-A8F352A9-39D0-465E-99DF-05D314DB0C83

P577

Q33390799-7729AE50-4B3F-4D81-89B7-0E308118131A

P698

Q33390799-C0915413-4838-4F03-8652-35CBDA932915

P356

P1433

P1476

Prevention of hepatitis B virus reactivation under rituximab therapy.

@en

P2093

Junji Tanaka

http://www.w3.org/2001/XMLSchema#string

Masahiro Asaka

http://www.w3.org/2001/XMLSchema#string

Masahiro Imamura

http://www.w3.org/2001/XMLSchema#string

Yoshiya Yamamoto

http://www.w3.org/2001/XMLSchema#string

Yutaka Tsutsumi

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.

Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease

Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study.

Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature.

The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).

Chronic hepatitis B.

Management of hepatitis B: 2000--summary of a workshop.

Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.

Occult hepatitis B virus infection and its clinical implications.

P304

1053-1061

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT.09.59

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20635919

http://www.w3.org/2001/XMLSchema#string